<img alt="" src="https://secure.perk0mean.com/184504.png" style="display:none;">

4G Clinical

Blog

A Site-Based Approach to Drug Accountability in Clinical Trials

4G Clinical

 

The key to seamless reconciliation is ensuring drug accountability. See how a site-based approach can reduce close out timelines and improve data accuracy.

Should Clinical Supply Planners be Statistical Experts?

4G Clinical

 

CSPs should be empowered with a good level of understanding what variables or information is critical to model supply planning (feasibility planning to study planning) so they can react and make decisions more effectively.

Strengthen Data Security with Cloud Technology

4G Clinical

 

Transitioning from traditional data servers to the cloud can lead to improved RTSM quality and more enhanced data security. See how!

As Clinical Trials Evolve, Will Your Systems Keep Up?

4G Clinical

 

Over the life of a study, the amount of time and resources spent on changes to a system can significantly impact the study – but do they have to?

A Non-Technical Guide To Understanding Modern RTSM Technology Stacks

4G Clinical

 

An RTSM has critical functions with direct patient impact. As trials grow in complexity, adopting modern tech is inevitable for companies hoping to keep up.

Site Voice #2 | If you could influence RTSM/clinical systems design, what would you change?

4G Clinical

 

4G Clinical partnered with SCRS to host their first Site Advisory Group for RTSM/IRT systems, where sites and sponsors gathered to discuss, among many other topics, what sites want from their IRT/RTSM.

Top 5 Questions to Ask When Considering RTSM Systems for Phase 1 Clinical Trials

4G Clinical

 

Did you know that Phase 1 trials can be even more complex than their Phase 2 and 3 counterparts? Don't let scale be the determining factor in choosing to leverage an RTSM. Here are 5 questions to ask when you consider an RTSM for your next Phase 1 study.

Site Voice | Partnering with Your Clinical Research Sites

4G Clinical

 

4G Clinical partnered with SCRS to host their first Site Advisory Group for RTSM/IRT systems, where sites and sponsors gathered to discuss, among many other topics, how sponsors can become more site-centric.

Top 6 Benefits of Leveraging an RTSM for Investigator Initiated Trials (IITs)

4G Clinical

 

Having an IRT/RTSM for your IITs will help with supply chain management since IITs traditionally draw from the same pool of drugs as manufacturer-sponsored studies. See how.

Clinical Trial Myth #4: If You Try To Get Into Clinical Research, You Will Not Be Eligible

4G Clinical

 

In the 4th Debunking Clinical Trial Myths video you'll hear from Joseph Kim from Eli Lilly and Company on the reason for strict enrollment criteria.